2021 China New Design Flucytosine - 6-(Chloromethyl)uracil CAS 18592-13-7 Tipiracil Hydrochloride Intermediate High Purity – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

With a positive and progressive attitude to customer's interest, our company continuously improves our product quality to meet the needs of customers and further focuses on safety, reliability, environmental requirements, and innovation of 259793-96-9, peptide, Weight 127.18, With a fast development and our customers come from Europe, United States, Africa and all over the world. Welcome to visit our factory and welcome your order, for further inquires please do not hesitate to contact us!

2021 China New Design Flucytosine - 6-(Chloromethyl)uracil CAS 18592-13-7 Tipiracil Hydrochloride Intermediate High Purity – Ruifu Detail:

Manufacturer Supply, High Quality and Competitive Price
Tipiracil hydrochloride (CAS: 183204-72-0) Related Intermediates
6-(Chloromethyl)uracil CAS: 18592-13-7
6-(Hydroxymethyl)uracil CAS: 22126-44-9
2-amino-4,5-dihydro-3H-pyrrole (HCl Salt) CAS: 7544-75-4

Chemical Name	6-(Chloromethyl)uracil
CAS Number	18592-13-7
CAT Number	RF-PI101
Stock Status	In Stock, Production Scale Up to Kilos and Tons
Molecular Formula	C₅H₅ClN₂O₂
Molecular Weight	160.56
Melting Point	257℃ (dec.) (lit.)
Solubility in N,N-DMF	Almost Transparency
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Powder
Purity / Analysis Method	≥98.0% (HPLC)
Identification	Conforms
Loss on Drying	≤0.50%
Test Standard	Enterprise Standard
Usage	Tipiracil hydrochloride Intermediate; Pharmaceutical Intermediates

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

121

6-(Chloromethyl)uracil (CAS: 18592-13-7), Intermediate of Tipiracil hydrochloride (CAS: 183204-72-0) in the treatment of Rectal cancer.
Tipiracil is a drug used in the treatment of cancer. It is approved for use in form of the combination drug trifluridine/tipiracil for the treatment of unresectable advanced or recurrent colorectal cancer.
Tipiracil helps maintain the blood concentration of trifluridine by inhibiting the enzyme thymidine phosphorylase which metabolizes trifluridine.

Product detail pictures:

Related Product Guide:

To continuously increase the administration process by virtue of the rule of "sincerely, good religion and excellent are the base of company development", we commonly absorb the essence of linked goods internationally, and continually build new solutions to fulfill the requires of shoppers for 2021 China New Design Flucytosine - 6-(Chloromethyl)uracil CAS 18592-13-7 Tipiracil Hydrochloride Intermediate High Purity – Ruifu , The product will supply to all over the world, such as: San Diego, Belgium, Costa Rica, Now we have a dedicated and aggressive sales team, and many branches, catering to our main customers. We have been looking for long-term business partnerships, and ensure our suppliers that they will undoubtedly benefit in both short and long run.